Full Text
The Full Text of this article is available as a PDF (63.0 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aronsson B., Granström M., Möllby R., Nord C. E. Serum antibody response to Clostridium difficile toxins in patients with Clostridium difficile diarrhoea. Infection. 1985 May-Jun;13(3):97–101. doi: 10.1007/BF01642866. [DOI] [PubMed] [Google Scholar]
- Borriello S. P., Honour P. Concomitance of cytotoxigenic and non-cytotoxigenic Clostridium difficile in stool specimens. J Clin Microbiol. 1983 Oct;18(4):1006–1007. doi: 10.1128/jcm.18.4.1006-1007.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fekety R. Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhea and colitis. American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol. 1997 May;92(5):739–750. [PubMed] [Google Scholar]
- Johnson S., Gerding D. N., Janoff E. N. Systemic and mucosal antibody responses to toxin A in patients infected with Clostridium difficile. J Infect Dis. 1992 Dec;166(6):1287–1294. doi: 10.1093/infdis/166.6.1287. [DOI] [PubMed] [Google Scholar]
- Johnson S., Sypura W. D., Gerding D. N., Ewing S. L., Janoff E. N. Selective neutralization of a bacterial enterotoxin by serum immunoglobulin A in response to mucosal disease. Infect Immun. 1995 Aug;63(8):3166–3173. doi: 10.1128/iai.63.8.3166-3173.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kyne L., Warny M., Qamar A., Kelly C. P. Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. N Engl J Med. 2000 Feb 10;342(6):390–397. doi: 10.1056/NEJM200002103420604. [DOI] [PubMed] [Google Scholar]
- Mathis J. N., Pilkinton L., McMillin D. E. Detection and transcription of toxin DNA in a nontoxigenic strain of Clostridium difficile. Curr Microbiol. 1999 Jun;38(6):324–328. doi: 10.1007/pl00006811. [DOI] [PubMed] [Google Scholar]
- Stubbe H., Berdoz J., Kraehenbuhl J. P., Corthésy B. Polymeric IgA is superior to monomeric IgA and IgG carrying the same variable domain in preventing Clostridium difficile toxin A damaging of T84 monolayers. J Immunol. 2000 Feb 15;164(4):1952–1960. doi: 10.4049/jimmunol.164.4.1952. [DOI] [PubMed] [Google Scholar]
- Warny M., Vaerman J. P., Avesani V., Delmée M. Human antibody response to Clostridium difficile toxin A in relation to clinical course of infection. Infect Immun. 1994 Feb;62(2):384–389. doi: 10.1128/iai.62.2.384-389.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wilcox M. H. Clostridium difficile infection: appendix. J Antimicrob Chemother. 1998 May;41 (Suppl 100):71–72. doi: 10.1093/jac/41.suppl_3.71. [DOI] [PubMed] [Google Scholar]